You may also like
Non-Occlusive Condition with the Better-Header Roller Pump: Impacts of Flow Dynamics and Hemolysis
Possible flow loss of the non-occlusion setting with the BH should be almost negligible in most clinical situations. The BH-NO350 demonstrated hemolytic characteristics similar to those of the BH-SO, but not as good as those of the CP.
1 min read
ZymoGenetics Submits Citizen Petition to FDA Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety
ZymoGenetics, Inc. (NASDAQ:ZGEN), announced today the submission of a Citizen Petition to the U.S. Food and Drug Administration (FDA) requesting that the FDA remove Thrombin-JMI® Thrombin, topical (bovine origin) from the market in the interest of patient safety. The Citizen Petition is prompted by recent reports of serious or fatal bleeding-related adverse events in surgical patients exposed to bovine (cattle-derived) thrombin.
3 min read
Tranexamic Acid and Convulsive Seizures After Isolated Coronary Artery Bypass Surgery: The Role of Cardiopulmonary Bypass and Renal Function
Our data in patients undergoing isolated CABG indicate no significant effect on CS risk by use of CPB when TXA doses of up to ∼2 g are given. However, caution regarding TXA administration is necessary in patients with renal impairment.
1 min read